Five Dividend Aristocrats with streaks ranging from 54 to 70 consecutive years of payout hikes are currently trading below Wall Street’s consensus price targets, and four of the five just beat their most recent EPS estimates. When a 64-year dividend raiser like Johnson & Johnson is raising 2026 EPS guidance to $11.45-$11.65 while still trading below target, the market is handing income investors a window. Here are five names where the dividend math, the earnings momentum, and the gap to analyst targets all point in the same direction.
1. Hormel Foods (The Surprise Pick)
Start with the name nobody on financial Twitter is bragging about. Hormel Foods (NYSE:HRL | HRL Price Prediction) just notched its 60th consecutive year of dividend increases, a streak that puts it in elite Dividend King territory, yet the stock has been treated like a turnaround story. After a brutal 15% EPS miss in Q3 FY25 triggered a guidance cut, shares collapsed and the dividend yield ballooned to 5.04%, an unusually fat number for a defensive packaged foods name.
The recovery is already showing up in the numbers. Hormel beat in Q2 FY26 with adjusted EPS of $0.40 versus a $0.35 consensus, marked its sixth consecutive quarter of organic top-line growth, and pushed adjusted operating margin to 9.9% from 9.1% year over year. With shares at $23.29 against an analyst target of $26.50, you are buying a Dividend King after a 20% one-year drawdown.
I have been watching consumer staples drawdowns for over a decade, and the pattern is consistent: when the streak survives the storm, the stock usually does too. The next name on this list raises the streak by another decade.
2. Procter & Gamble (The 70-Year Anchor)
If Hormel is the rebound, Procter & Gamble (NYSE:PG) is the foundation. P&G just delivered its 70th consecutive annual dividend increase, with 136 straight years of dividend payments dating back to 1890. That is a constant of the universe. And yet shares at $140.78 sit below the analyst target of $163.77, after a 13% decline over the past year.
The Q3 FY26 print was the kind that usually gets a stock bid. Core EPS of $1.59 beat the $1.56 consensus, net sales of $21.24 billion rose 7.4% year over year, and all five segments grew with Beauty leading at 7% organic. Management still plans to return roughly $10 billion in dividends plus $5 billion in buybacks in FY26 despite a ~$400 million after-tax tariff headwind.
Tide, Pampers, Gillette, Crest, Charmin: these are the products that get bought whether the economy is up, down, or sideways. The next stock takes that same defensive logic and stretches it into the highest-margin corner of the market.
3. Johnson & Johnson (The Healthcare Compounder)
The obvious heavyweight. Johnson & Johnson (NYSE:JNJ) just clocked its 64th consecutive year of dividend increases, raising the quarterly payout 3.1% to $1.34. The setup here is rare: a defensive name throwing off pharma-grade growth. Shares at $228.17 are still below the analyst target of $252.87, even after a 53% one-year gain.
Q1 FY26 was the fourth straight EPS beat: $2.70 adjusted EPS versus $2.68 consensus, revenue of $24.06 billion up 9.9%, with Innovative Medicine accelerating to +11.2%. The oncology engine is firing on all cylinders: DARZALEX +22.5%, CARVYKTI +62.1%, TREMFYA +68.3%. CEO Joaquin Duato called it a “strong start to 2026…delivering on its promise for a year of accelerated growth.”
Management has already raised 2026 EPS guidance once. If oncology growth keeps masking Stelara’s biosimilar erosion, this gap to target closes. Now we move from healthcare to the snack aisle, where a fresh $10 billion buyback just landed.
4. PepsiCo (The Buyback Just Got Bigger)
PepsiCo (NASDAQ:PEP) is the dividend story everyone forgot about, and that is precisely the opportunity. The company just announced its 54th consecutive annual dividend increase, a 4% bump that lifts the annualized payout to $5.92 per share, alongside a fresh $10 billion buyback authorization through February 2030. Shares at $142.15 sit well below the analyst target of $171.05, with a forward P/E of just 17.
The Q1 FY26 numbers refute the “Pepsi is broken” thesis. Core EPS of $1.61 beat the $1.54 consensus, revenue of $19.44 billion topped expectations, and operating margin expanded 210 basis points to 16.5%. International is doing the heavy lifting: EMEA core operating profit +29%, Asia Pacific Foods +35%.
With a 4.01% dividend yield and roughly $8.9 billion in total shareholder returns planned for 2026, you are being paid handsomely to wait for North America volume to fully turn. Speaking of momentum, the final name on this list is the one quietly raising guidance while the market looks the other way.
5. Coca-Cola (The Payoff)
Here is the punchline. Coca-Cola (NYSE:KO) is on a 63rd consecutive year of dividend increases and just did something the other four names did not: it raised full-year guidance. The Q1 FY26 print was a clean sweep: EPS of $0.86 versus $0.81 consensus (the fourth straight beat), revenue of $12.47 billion up 12.1% year over year, and unit case volume +3% led by China, the US, and India.
Management now expects organic revenue growth of 4-5% and comparable EPS growth of 8-9% for 2026, with free cash flow targeted near $12.2 billion. Operating margin expanded to 35.0% from 32.9%, the kind of profitability beverage analysts dream about. Shares at $76.82 still sit below the analyst target of $86.06, despite a 11% year-to-date gain.
Coca-Cola paid $8.8 billion in dividends in 2025, added $477 million in Q1 buybacks, and is doing it all with a beta of 0.36. This is the textbook combination: low volatility, raised guidance, expanding margins, and a gap to target.
The Setup
Five Dividend Aristocrats. Streaks ranging from 54 to 70 years. Every name trading below consensus target. Four of five beat their last quarter, and Coca-Cola actually raised guidance into a market that is treating staples like an afterthought. Dividend Kings rarely go on sale at the same time, and history says the window does not stay open long once earnings momentum becomes visible.
Top Gaining Stocks
Top Losing Stocks